Jordan Pasternack, MD
Foot and Ankle Surgery · Greenwich, CTNPI 1801250485
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 45.0% of the total. Reporting peaked in 2023 at $1,772 and has fallen 52.3% since, to $845 in 2025.
Across 37 payments — averaging $75.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Gotham Surgical Solutions & Devices, Inc.$763
- Exactech, Inc.$315
- Stryker$252
- Vericel Corporation$69
- Amgen$37
- plus $95 from 4 others
What the payments were for
- Travel & lodging$1,43051%
- Food & beverage$1,15842%
- Education$1937%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 16 | $1,251 |
| Gotham Surgical Solutions & Devices, Inc. | 8 | $763 |
| Exactech, Inc. | 3 | $315 |
| Stryker | 4 | $252 |
| Vericel Corporation | 1 | $69 |
| Amgen | 1 | $37 |
| Vertex | 1 | $27 |
| Johnson & Johnson | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Bioventus LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VANTAGE$256
- PROSTEP MICA$193
How this compares
$2,782 in reported general payments places this provider in the 55th percentile of 89 foot and ankle surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Greenwich
- Sean PedenGreenwich$4K
- Usman AleemGreenwich$4K
- Heba JafriGreenwich$2K
- Thomas McDonaldEnfield$241K
- Jossie AbrahamNorwalk$152K
- Gabriel GambardellaBloomfield$99K
- David CaminearHamden$47K
- James DejesusNaugatuck$40K
- William ProbascoFairfield$26K
- Adebola AdelekeMiddletown$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.